Excelsior Medical Co., Ltd.TWSE: 4104

The Board of Directors approved Q2 2022 consolidated financial statements.

· Issued by Excelsior Medical Co., Ltd.
Close
Today's Information

Provided by: EXCELSIOR MEDICAL CO.,LTD
SEQ_NO 1 Date of announcement 2022/08/04 Time of announcement 17:33:19
Subject
 The Board of Directors approved Q2 2022
consolidated financial statements.
Date of events 2022/08/04 To which item it meets paragraph 31
Statement
1.Date of submission to the board of directors or approval by the board of
 directors:2022/08/04
2.Date of approval by the audit committee:2022/08/04
3.Start and end dates of financial reports or annual self-assessed financial
 information of the reporting period (XXXX/XX/XX~XXXX/XX/XX):
2022/01/01~2022/06/30
4.Operating revenue accumulated from 1/1 to end of the period
(thousand NTD):3,382,621
5.Gross profit (loss) from operations accumulated from 1/1 to end of
the period (thousand NTD):740,566
6.Net operating income (loss) accumulated from 1/1 to end of the period
(thousand NTD):308,689
7.Profit (loss) before tax accumulated from 1/1 to end of the period
 (thousand NTD):459,855
8.Profit (loss) accumulated from 1/1 to end of the period
 (thousand NTD):369,907
9.Profit (loss) during the period attributable to owners of parent
accumulated from 1/1 to end of the period (thousand NTD):308,122
10.Basic earnings (loss) per share accumulated from 1/1 to end of
the period (NTD):2.18
11.Total assets end of the period (thousand NTD):16,014,344
12.Total liabilities end of the period
(thousand NTD):6,199,849
13.Equity attributable to owners of parent end of the
period (thousand NTD):7,810,783
14.Any other matters that need to be specified:None.

Earlier from Excelsior Medical

All Excelsior Medical news releases